These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 146524)

  • 21. Neurochemical approaches to the treatment of senile dementia.
    Growdon JH; Corkin S
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():281-96. PubMed ID: 7413654
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutical approach to involuntary movements (author's transl)].
    Allain H; Sabouraud O
    Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
    Stahl SM; Yesavage JA; Berger PA
    J Clin Psychiatry; 1982 Nov; 43(11):445-6. PubMed ID: 7174619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging treatments: replacement therapy with choline or lecithin in neurological diseases.
    Barbeau A
    Can J Neurol Sci; 1978 Feb; 5(1):157-60. PubMed ID: 148319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huntington's Chorea and dimethylaminoethanol (deanol).
    Amsterdam JD; Dubin W
    J Clin Psychiatry; 1978 Jul; 39(7):626-8. PubMed ID: 150413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].
    Karniol IG; Giampietro AC; Moura DS; Vilela WA; Oliveira MA; Zuardi AW
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroleptic tardive dyskinesias. Completion of the inquiry regarding 1,480 psychiatric hospital patients].
    Bourgeois M; Boueilh P; Peyre C; Gauthier-Bernard F
    Ann Med Psychol (Paris); 1977 Apr; 1(4):660-79. PubMed ID: 603190
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cholinergic system and memory: amelioration of ethanol-induced memory deficiency by physostigmine in rat.
    Arendt T; Schugens MM; Bigl V
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):251-61. PubMed ID: 2130647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic characterization of tardive dyskinesia.
    Lieberman J; Pollack S; Lesser M; Kane J
    J Clin Psychopharmacol; 1988 Aug; 8(4):254-60. PubMed ID: 3209717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study.
    Gelenberg AJ; Doller-Wojcik JC; Growdon JH
    Am J Psychiatry; 1979 Jun; 136(6):772-6. PubMed ID: 375755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.
    Simpson GM; Yadalam KG; Stephanos MJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):49S-51S. PubMed ID: 2906069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinergic treatments for tardive dyskinesia.
    Alphs LD; Davis JM
    Mod Probl Pharmacopsychiatry; 1983; 21():168-86. PubMed ID: 6140629
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.